منابع مشابه
Overview, prevention and management of chemotherapy extravasation.
Chemotherapy extravasation remains an accidental complication of chemotherapy administration and may result in serious damage to patients. We review in this article the clinical aspects of chemotherapy extravasation and latest advances in definitions, classification, prevention, management and guidelines. We review the grading of extravasation and tissue damage according to various chemotherape...
متن کاملVesicant chemotherapy extravasation antidotes and treatments.
Oncology nurses and pharmacists often are given the responsibility of developing or updating institutional policies to manage vesicant chemotherapy extravasations. Antidote and treatment recommendations of vesicant chemotherapy manufacturers, antidotes and treatments approved by the U.S. Food and Drug Administration (FDA), and guidelines and recommendations made by professional oncology organiz...
متن کاملCancer chemotherapy agent-induced perivenous extravasation injuries.
Chemotherapy occupies a well defined role in tumour management and has transformed the prognosis of many haematological neoplasms and solid tumours. Unfortunately, the large majority of chemotherapeutic agents currently in use are toxic to tissues in general and produce tissue necrosis on perivenous extravasation. The sequelae add considerably to the morbidity of an already seriously ill patien...
متن کاملChemotherapy extravasation at hospital pulau pinang, malaysia.
PURPOSE Extravasation with intravenous chemotherapy is a common complication of chemotherapy which carries the risk of devastating complications. This study aims to determine the rate of extravasation with intravenous chemotherapy in a major hospital where chemotherapy is delivered in various departments other than the oncology department. PATIENTS AND METHODS All patients who underwent intra...
متن کاملManagement of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines.
EONS Clinical Practice Guidelines J. A. Pérez Fidalgo, MD1, L. García Fabregat, RN1, A. Cervantes, MD1, A. Margulies, RN2, C. Vidall, RN3 & F. Roila, MD4 on behalf of the ESMO Guidelines Working Group* Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain; European Oncology Nursing Society, Zurich, Switzerland; Healthcare at...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Blood & Lymph
سال: 2017
ISSN: 2165-7831
DOI: 10.4172/2165-7831.1000i103